Comparison Overview

Koneksa

VS

SUN PHARMA

Koneksa

285 Fulton St, New York, 10007, US
Last Update: 2026-02-20
View Profile
Between 750 and 799
http://www.koneksahealth.com

Koneksa transforms complex multimodal measures into actionable clinical insights. Its platform unifies digital biomarkers, wearable sensor data, patient-reported outcomes, and clinical measures to deliver a deeper view of disease, treatment response, and patient well-being. With a remote-first, patient-centric approach, Koneksa reduces site burden, improves accessibility, and captures continuous real-world evidence. By accelerating trial timelines, enhancing decision-making, and supporting participant retention, Koneksa advances therapeutic innovation from early discovery through post-market studies.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 45
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

SUN PHARMA

Sun House, CTS No. 201 B/1,, Mumbai, 400063, IN
Last Update: 2026-04-01
Between 800 and 849
http://www.sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 44,544
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/koneksa-health.jpeg
Koneksa
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/sun-pharma.jpeg
SUN PHARMA
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Koneksa
100%
Compliance Rate
0/4 Standards Verified
SUN PHARMA
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Koneksa in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for SUN PHARMA in 2026.

Incident History — Koneksa (X = Date, Y = Severity)

Koneksa cyber incidents detection timeline including parent company and subsidiaries

Incident History — SUN PHARMA (X = Date, Y = Severity)

SUN PHARMA cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/koneksa-health.jpeg
Koneksa
Incidents

No Incident

https://images.rankiteo.com/companyimages/sun-pharma.jpeg
SUN PHARMA
Incidents

No Incident

FAQ

SUN PHARMA company demonstrates a stronger AI Cybersecurity Score compared to Koneksa company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, SUN PHARMA company has disclosed a higher number of cyber incidents compared to Koneksa company.

In the current year, SUN PHARMA company and Koneksa company have not reported any cyber incidents.

Neither SUN PHARMA company nor Koneksa company has reported experiencing a ransomware attack publicly.

Neither SUN PHARMA company nor Koneksa company has reported experiencing a data breach publicly.

Neither SUN PHARMA company nor Koneksa company has reported experiencing targeted cyberattacks publicly.

Neither Koneksa company nor SUN PHARMA company has reported experiencing or disclosing vulnerabilities publicly.

Neither Koneksa nor SUN PHARMA holds any compliance certifications.

Neither company holds any compliance certifications.

SUN PHARMA company has more subsidiaries worldwide compared to Koneksa company.

SUN PHARMA company employs more people globally than Koneksa company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Koneksa nor SUN PHARMA holds SOC 2 Type 1 certification.

Neither Koneksa nor SUN PHARMA holds SOC 2 Type 2 certification.

Neither Koneksa nor SUN PHARMA holds ISO 27001 certification.

Neither Koneksa nor SUN PHARMA holds PCI DSS certification.

Neither Koneksa nor SUN PHARMA holds HIPAA certification.

Neither Koneksa nor SUN PHARMA holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References